Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) (Unaudited)

v3.22.1
Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Total
Preferred Stock
Series A Preferred Stock
Preferred Stock
Series B Preferred Stock
Preferred Stock
Series C Preferred Stock
Common Stock
Additional Paid-in Capital
AOCI Attributable to Parent
Accumulated Deficit
Beginning balance at Dec. 31, 2020 $ (48,736) $ 52,809 $ 35,228 $ 65,222 $ 2 $ 10,131 $ (982) $ (211,146)
Beginning balance, shares at Dec. 31, 2020 [1]   21,615,723 8,306,818 12,804,176 17,664,015      
Exercise of stock options 295         295    
Exercise of stock options, shares [1]         251,500      
Stock compensation expense 2,507         2,507    
Net loss (19,698)             (19,698)
Foreign currency translation adjustments 32           32  
Ending balance at Mar. 31, 2021 (65,600) $ 52,809 $ 35,228 $ 65,222 $ 2 12,933 (950) (230,844)
Ending balance, shares at Mar. 31, 2021 [1]   21,615,723 8,306,818 12,804,176 17,915,515      
Beginning balance at Dec. 31, 2021 188,864       $ 15 418,575 732 (230,458)
Beginning balance, shares at Dec. 31, 2021         151,154,614      
Exercise of stock options $ 638         638    
Exercise of stock options, shares 492,064       492,064      
Vesting of restricted stock units, shares         4,014      
Stock compensation expense $ 2,289         2,289    
Net loss (18,158)             (18,158)
Foreign currency translation adjustments 1,859           1,859  
Ending balance at Mar. 31, 2022 $ 175,492       $ 15 $ 421,502 $ 2,591 $ (248,616)
Ending balance, shares at Mar. 31, 2022         151,650,692      
[1] The shares of the Company’s common and convertible preferred stock, prior to the Merger (as defined in Note 1) have been retroactively restated to reflect the exchange ratio of approximately 1.7058 established in the Merger.